Suppr超能文献

分子方法在碳青霉烯酶检测中的应用

Application of Molecular Methods for Carbapenemase Detection.

作者信息

Bilozor Anastasia, Balode Arta, Chakhunashvili Giorgi, Chumachenko Tetyana, Egorova Svetlana, Ivanova Marina, Kaftyreva Liidia, Kõljalg Siiri, Kõressaar Triinu, Lysenko Olga, Miciuleviciene Jolanta, Mändar Reet, Lis Danuta O, Wesolowska Monika Pomorska, Ratnik Kaspar, Remm Maido, Rudzko Jelena, Rööp Tiiu, Saule Mara, Sepp Epp, Shyshporonok Julia, Titov Leonid, Tsereteli David, Naaber Paul

机构信息

Department of Microbiology, Central Laboratory, East-Tallinn Central Hospital, Tallinn, Estonia.

Department of Microbiology, Institute of Biomedicine and Translational Medicine, University of Tartu, Tartu, Estonia.

出版信息

Front Microbiol. 2019 Aug 2;10:1755. doi: 10.3389/fmicb.2019.01755. eCollection 2019.

Abstract

This study has evaluated the correlation between different carbapenemases detection methods on carbapenem non-susceptible strains from Northern and Eastern Europe; 31 institutions in 9 countries participated in the research project, namely Finland, Estonia, Latvia, Lithuania, Russia, St. Petersburg, Poland, Belarus, Ukraine, and Georgia. During the research program, a total of 5,001 clinical isolates were screened for any carbapenem non-susceptibility by the disk diffusion method, Vitek 2 or Phoenix system following the EUCAST guideline on detection of resistance mechanisms, version 1.0. Strains isolated from outpatients and hospitalized patients from April 2015 to June 2015 were included. All types of samples (blood, pus, urine, etc.) excluding fecal screening or fecal colonization samples have been represented. In total, 171 carbapenemase screening-positive isolates (3.42%) were found and characterized. Several methods were used for detection of carbapenemases production, including Luminex assay (PCR and hybridization), whole genome sequencing, MALDI-TOF based Imipenem degradation assay, and immunochromatography testing. Minimal inhibitory concentration determination for Meropenem by agar-based gradient method was also used. Finally, 83 strains were carbapenemase negative by all confirmation methods (49.4% of all screening-positive ones), 74 - positive by three methods (44.0%), 8 - positive by two methods (4.8%) and 3 - positive by only one method (1.8%). The sensitivity of the tests was 96.3% for Whole genome sequencing and MALDI-TOF assay (both three undetected cases), and 95.1% for Luminex-Carba (4 undetected cases). The most commonly detected carbapenemases were NDM ( = 54) and OXA-48 ( = 26), followed by KPC-2, VIM-5, and OXA-72 (one case of each). Our results showed that different types of carbapenemases can be detected in the countries involved in the project. The sensitivity of our methods for carbapenemase detection (including screening as a first step and further confirmation tests) was >95%, but we would recommend using different methods to increase the sensitivity of detection and make it more precise.

摘要

本研究评估了北欧和东欧碳青霉烯类不敏感菌株中不同碳青霉烯酶检测方法之间的相关性;9个国家的31个机构参与了该研究项目,分别是芬兰、爱沙尼亚、拉脱维亚、立陶宛、俄罗斯、圣彼得堡、波兰、白俄罗斯、乌克兰和格鲁吉亚。在研究项目期间,按照欧盟药敏试验委员会(EUCAST)关于耐药机制检测的指南1.0版,采用纸片扩散法、Vitek 2或Phoenix系统,共筛选了5001株临床分离株,以检测是否对任何碳青霉烯类药物不敏感。纳入了2015年4月至2015年6月从门诊患者和住院患者中分离出的菌株。除粪便筛查或粪便定植样本外,所有类型的样本(血液、脓液、尿液等)均有代表。总共发现并鉴定了171株碳青霉烯酶筛查阳性分离株(3.42%)。采用了几种方法检测碳青霉烯酶的产生,包括Luminex检测法(PCR和杂交)、全基因组测序、基于基质辅助激光解吸电离飞行时间质谱(MALDI-TOF)的亚胺培南降解试验以及免疫层析检测。还采用基于琼脂的梯度法测定美罗培南的最低抑菌浓度。最后,83株菌株经所有确证方法检测均为碳青霉烯酶阴性(占所有筛查阳性菌株的49.4%),74株经三种方法检测为阳性(44.0%),8株经两种方法检测为阳性(4.8%),3株仅经一种方法检测为阳性(1.8%)。全基因组测序和MALDI-TOF检测的敏感度为96.3%(均有3例未检测到),Luminex-Carba检测的敏感度为95.1%(4例未检测到)。最常检测到的碳青霉烯酶是NDM(=54)和OXA-48(=26),其次是KPC-2、VIM-5和OXA-72(各1例)。我们的结果表明,在参与该项目的国家中可以检测到不同类型的碳青霉烯酶。我们的碳青霉烯酶检测方法(包括作为第一步的筛查和进一步的确证试验)的敏感度>95%,但我们建议使用不同方法以提高检测敏感度并使其更精确。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b8c8/6687770/81ea8b20653f/fmicb-10-01755-g001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验